New technology partially revives pig organs

Publicly released:
International
Robina Weermeijer
Robina Weermeijer

When a mammal's blood flow stops, it triggers a cascade of events that lead to cell death and organ injury. US scientists have created a system that pumps a fluid that can counteract this cascade, and preserve tissues in pigs when initiated one hour after death. They say this approach could have the potential to be applied to humans to increase organ availability for transplantation, but more investigation is needed to confirm this.

News release

From: Springer Nature

A system that can restore some molecular and cellular functions and can preserve tissues in pigs when initiated one hour after death is reported in Nature this week. No evidence of electrical brain activity associated with normal brain function was observed during the procedure. This approach may have the potential to increase organ availability for transplantation, although further research is needed to understand the implications and applications of these findings.

When blood flow ceases in mammals, the lack of oxygen and nutrient circulation triggers a cascade of events that lead to cellular death and organ injury. Methods to preserve tissues and promote recovery have been demonstrated in isolated organs, but scaling up such interventions to the whole-body level has proven challenging. Nenad Sestan and colleagues adapt one such technology — BrainEx, which was shown to restore some function in pig brains hours after death — for whole-body use in large mammals.

The scaled-up system, named OrganEx, is connected to the circulatory system and pumps a fluid containing factors that can counteract the damaging metabolic and electrolyte imbalances that result from blood flow cessation. The authors test the system in pigs one hour after cardiac arrest and compare it with a more traditional system for restoring circulation: an extracorporeal membrane oxygenation system (ECMO). OrganEx is shown to preserve tissue integrity, decrease cell death and restore selected molecular and cellular processes across multiple vital organs (such as the heart, brain, liver and kidneys). Organs treated with OrganEx displayed fewer signs of haemorrhage or tissue swelling than those treated with ECMO. They also observe organ-specific and cell type-specific gene expression patterns that indicate that repair processes are occurring within the body.

Further exploration and development is needed to fully understand the potential of OrganEx to aid cellular recovery after death or interrupted blood circulation, the authors note. The findings highlight a previously unappreciated capacity of the mammalian body to partially recover after an interruption to blood flow, which could increase organ availability for transplantation, the authors conclude.

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research , Web page
Journal/
conference:
Nature
Organisation/s: Yale University, USA
Funder: This work was supported by the NIH BRAIN Initiative grants MH117064, MH117064-01S1, R21DK128662, T32GM136651, F30HD106694 and Schmidt Futures. Competing interests: D.A., Z.V. and N.S. have disclosed these findings to the Yale Office of Cooperative Research, which has filed a patent to ensure broad use of the technology. All protocols, methods, perfusate formulations and components of the OrganEx technology remain freely available for academic and non-profit research. Although the Hemopure product was provided in accordance with a material transfer agreement between HbO2 Therapeutics and Yale University through N.S., the Company had no influence on the study design or interpretation of the results. No author has a financial stake in, or receives compensation from, HbO2 Therapeutics.
Media Contact/s
Contact details are only visible to registered journalists.